TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages
© Yuan et al.; licensee BioMed Central Ltd. 2013
Received: 28 August 2012
Accepted: 12 March 2013
Published: 22 March 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|28 Aug 2012||Submitted||Original manuscript|
|9 Oct 2012||Reviewed||Reviewer Report - Carmen Blanco-Aparicio|
|11 Oct 2012||Reviewed||Reviewer Report - Hiroki Chikumi|
|15 Oct 2012||Reviewed||Reviewer Report - Laura Moro|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|13 Dec 2012||Reviewed||Reviewer Report - Laura Moro|
|20 Dec 2012||Reviewed||Reviewer Report - Carmen Blanco-Aparicio|
|1 Jan 2013||Reviewed||Reviewer Report - Hiroki Chikumi|
|15 Jan 2013||Author responded||Author comments - Bao-Zhu Yuan|
|Resubmission - Version 3|
|15 Jan 2013||Submitted||Manuscript version 3|
|12 Mar 2013||Editorially accepted|
|22 Mar 2013||Article published||10.1186/1471-2407-13-140|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.